These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 3489186)

  • 21. Coupling and cross-presentation.
    Heath WR; Carbone FR
    Nature; 2005 Mar; 434(7029):27-8. PubMed ID: 15744280
    [No Abstract]   [Full Text] [Related]  

  • 22. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the capacity of B cells to serve as antigen-presenting cells.
    Chesnut RW; Grey HM
    J Immunol; 1981 Mar; 126(3):1075-9. PubMed ID: 6970212
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages.
    Abraham R; Singh N; Mukhopadhyay A; Basu SK; Bal V; Rath S
    J Immunol; 1995 Jan; 154(1):1-8. PubMed ID: 7527810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell biology. Peptides, scrambled and stitched.
    Shastri N
    Science; 2006 Sep; 313(5792):1398-9. PubMed ID: 16959995
    [No Abstract]   [Full Text] [Related]  

  • 29. B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway.
    Clark MR; Massenburg D; Siemasko K; Hou P; Zhang M
    Curr Opin Immunol; 2004 Jun; 16(3):382-7. PubMed ID: 15134789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coupling of T-cell activation with T-cell receptor assembly.
    Terhorst C; Exley M; Franco R; Hall C; Kang J; Mueller B; Sancho J; She J; Wileman T
    Year Immunol; 1993; 7():1-24. PubMed ID: 8372498
    [No Abstract]   [Full Text] [Related]  

  • 31. The T cell receptors.
    Marrack P; Kappler JW
    Chem Immunol; 1990; 49():69-81. PubMed ID: 2190587
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of the major histocompatibility complex class I antigens in tumor growth and metastasis.
    Tanaka K; Yoshioka T; Bieberich C; Jay G
    Annu Rev Immunol; 1988; 6():359-80. PubMed ID: 3289570
    [No Abstract]   [Full Text] [Related]  

  • 33. A one and a half receptor model for MHC-restricted antigen recognition by T lymphocytes.
    Pernis B; Axel R
    Cell; 1985 May; 41(1):13-6. PubMed ID: 2581695
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunology. Making a molecular match.
    Germain RN
    Nature; 1990 Mar; 344(6261):19-22. PubMed ID: 2406610
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis.
    Chattergoon MA; Kim JJ; Yang JS; Robinson TM; Lee DJ; Dentchev T; Wilson DM; Ayyavoo V; Weiner DB
    Nat Biotechnol; 2000 Sep; 18(9):974-9. PubMed ID: 10973219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell responses to minor histocompatibility antigens.
    Lai PK; Waterfield JD; Gascoigne NR; Sharrock CE; Mitchison NA
    Immunology; 1982 Oct; 47(2):371-81. PubMed ID: 6214502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Structure and function of MHC: molecular mechanisms for antigen processing and antigen presentation to T cells].
    Nishimura Y
    Tanpakushitsu Kakusan Koso; 2000 May; 45(7):1205-18. PubMed ID: 10806862
    [No Abstract]   [Full Text] [Related]  

  • 38. Fate of intercellular MHC-peptide-T-cell receptor complexes during T-cell activation.
    Clark BR
    J Mol Recognit; 1995; 8(1-2):63-6. PubMed ID: 7598954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The binary logic of antigen processing and presentation to T cells.
    Yewdell JW; Bennink JR
    Cell; 1990 Jul; 62(2):203-6. PubMed ID: 1695549
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune Responses: costimulatory receptors have their say.
    Weintraub BC; Goodnow CC
    Curr Biol; 1998 Jul 30-Aug 13; 8(16):R575-7. PubMed ID: 9707395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.